Fortress Biotech

Fortress Biotech EBITDA per Share

The EBITDA per Share of Fortress Biotech (FBIO) as of Nov 3, 2026 is -1.96 USD. In the previous year, EBITDA per Share was -5.25 USD — a change of -62.60% (higher).

EBITDA per Share

-1.96USD

YoY

-62.60%

Last updated:

EBITDA per Share of Fortress Biotech is 2025 -1.96 USD. EBITDA per Share of Fortress Biotech was 2024 -5.25 USD. It decreases by -62.60% higher compared to the previous year.

The Fortress Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-42.30 USD
Jan 1, 2019
-27.86 USD
Jan 1, 2020
-17.72 USD
Jan 1, 2021
-33.82 USD
Jan 1, 2022
-33.61 USD
Jan 1, 2023
-18.16 USD
Jan 1, 2024
-5.25 USD
Jan 1, 2025
-1.96 USD
The Fortress Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
-1.96USD-62.60%
-5.25USD-71.08%
-18.16USD-45.97%
-33.61USD-0.61%
-33.82USD+90.85%
-17.72USD-36.40%
-27.86USD-34.13%
-42.30USD+24.51%
-33.97USD+34.66%
-25.23USD+31.37%
-19.20USD+131.54%
-8.29USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Fortress Biotech Stock analysis

What does Fortress Biotech do? Fortress Biotech Inc. is a biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on biotechnology. The company develops and commercializes novel pharmaceutical and biotechnology products through its 11 operating subsidiaries, which include 4 commercial-stage programs and 25 development-stage programs targeting therapeutic areas such as Immuno-oncology, Hematology, Gene Therapy, and Rare Diseases. Fortress employs 78 full-time staff and was listed on the stock market on 17 November 2011. Fortress Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fortress Biotech stock

EBITDA per Share of Fortress Biotech is -1.96 USD in 2025.

EBITDA per Share of Fortress Biotech changed from -5.25 USD to -1.96 USD, representing a -62.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Fortress Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Fortress Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Fortress Biotech